Sundry Pictures/iStock Editorial through Getty Photos
At-home COVID-19 checks have bought out at some pharmacy places of CVS Well being (NYSE:CVS) as a summer season spike in case numbers has fueled the demand, Bloomberg Information reported, citing information as of Friday afternoon.
CVS (CVS) places in Houston, Austin, and Reno, Nevada, had been among the many pharmacy retailers that reported stock-outs for all manufacturers of at-home COVID-19 checks. Nonetheless, the corporate mentioned that not less than one model of check was out there throughout 91% of its retailer community.
Becton, Dickinson (BDX), QuidelOrtho (QDEL), Abbott Laboratories (ABT), and Roche (OTCQX:RHHBY) (OTCQX:RHHBF) are among the many largest producers of at-home COVID-19 checks within the U.S.
The uptick in demand coincides with an increase in COVID-19 infections. In line with information from the U.S. Facilities for Illness Management and Prevention (CDC) for the week ending July 27, 16% of COVID checks have turned optimistic in comparison with 14% every week in the past.
In the meantime, CVS’ (CVS) rival Walgreens (WBA) mentioned it has ample provides of COVID checks, and the corporate’s web site additionally indicated there have been no stock-outs throughout its pharmacy community.
Nonetheless, Walgreens (WBA) and several other unbiased pharmacies in New York Metropolis mentioned the demand has risen sharply in latest months.
Walgreens (WBA) spokesperson Molly Sheehan additionally confirmed that the purchases of at-home COVID checks have approached the very best degree for the reason that vacation season. Nonetheless, Abbott (ABT), the maker of Binax Covid checks, reported a ~61% YoY decline in COVID-19 testing gross sales with its Q2 2024 outcomes final month.
